• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔癌患者队列中的营养因素与生存情况

Nutritional factors and survival in a cohort of patients with oral cancer.

作者信息

Buscemi Paolo, Randazzo Cristiana, Buscemi Carola, Barile Anna Maria, Finamore Elena, Caruso Roberta, Colombrita Piero, Lombardo Martina, Cangemi Serena, Zucchi Giulia, Cordova Adriana, Lo Casto Antonio, Buscemi Silvio

机构信息

Sezione di Scienze Radiologiche, Dipartimento di Biomedicina, Neuroscienze e Diagnostica Avanzata (BIND), University of Palermo, Palermo, Italy.

Dipartimento di Promozione della Salute, Materno-Infantile, Medicina Interna e Specialistica di Eccellenza (PROMISE), University of Palermo, Palermo, Italy.

出版信息

Front Nutr. 2025 Mar 11;12:1530460. doi: 10.3389/fnut.2025.1530460. eCollection 2025.

DOI:10.3389/fnut.2025.1530460
PMID:40151344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11948537/
Abstract

BACKGROUND

Malnutrition commonly affects patients with oral squamous cell carcinoma (OSCC), which contributes to worsening prognosis. Moreover, specific strategies for diagnosing and managing malnutrition in OSCC are lacking. We aimed to investigate if the modality of nutritional treatment as standard oral (ON) or artificial enteral nutrition (AN), assigned by a dedicated nutritional team or not, influences survival in patients with OSCC. Moreover, given the difficulties in obtaining adequate nutritional evaluation in patients with OSCC we preliminary evaluated the magnetic resonance imaging volumetric reconstruction of posterior paraspinal muscles at the level of the third cervical vertebra (MRI-C3) as a tentative new approach to investigate sarcopenia.

METHODS

This retrospective study included 52 consecutive patients with OSCC who underwent surgery at the University Hospital of Palermo (I) from Jan 2020 to May 2023. In-hospital nutritional support was provided by a dedicated team. The patients were retrospectively compared with a control group of 11 patients who were surgically treated for OSCC between January and December 2019 in the same unit of surgery, in the absence of a dedicated nutritional team. Upon discharge, the nutritional treatment consisted of ON or AN. In 2020-2023, industrially produced special medical food formulations were used rather than natural foods as it was in use in 2019; also, adequate protein supplements were assigned in order to reach the recommended protein intake of 1-0-1.2 g/kg ideal body weight. The MRI-C3 volumetric reconstruction was obtained in 16 patients.

FINDINGS

As per-protocol, the patients were categorized according to pre-surgery TNM stage: groups A (TNM stages I-III) and B (IVa-IVc). The prevalence of group A patients was 59.6% in the case group and 85.7% in the control group ( < 0.001), with higher survival rates at follow-up in the control group (80.5% vs. 27.3%), therefore, the two historical groups were not comparable. Given the limited number of cases, all patients were included in a unique group. Advanced stages of OSCC (log-rank test,  < 0.001) and AN ( < 0.001) were independently associated with a lower survival rates. The 3-12 month post-surgery MRI_C3 volume increased in patients who received ON treatment and decreased in those who received AN treatment ( < 0.001).

CONCLUSION

AN is associated with lower survival probability than ON in patients with OSCC. The MRI-C3 measurement of paravertebral muscles is a promising technique for detecting sarcopenia that needs to be confirmed by further studies including larger groups of patients.

摘要

背景

营养不良常影响口腔鳞状细胞癌(OSCC)患者,这会导致预后恶化。此外,缺乏诊断和管理OSCC患者营养不良的具体策略。我们旨在研究由专门的营养团队分配的标准口服营养(ON)或人工肠内营养(AN)的营养治疗方式是否会影响OSCC患者的生存率。此外,鉴于在OSCC患者中进行充分营养评估存在困难,我们初步评估了第三颈椎水平(MRI-C3)的椎旁肌磁共振成像体积重建作为一种研究肌肉减少症的新方法。

方法

这项回顾性研究纳入了2020年1月至2023年5月在巴勒莫大学医院(I)接受手术的52例连续OSCC患者。住院期间的营养支持由一个专门的团队提供。将这些患者与2019年1月至12月在同一手术科室接受OSCC手术治疗的11例患者组成的对照组进行回顾性比较,该对照组没有专门的营养团队。出院时,营养治疗包括ON或AN。在2020 - 2023年,使用了工业生产的特殊医学食品配方,而不是2019年使用的天然食品;此外,还分配了足够的蛋白质补充剂,以达到推荐的每千克理想体重1.0 - 1.2克蛋白质的摄入量。对16例患者进行了MRI-C3体积重建。

结果

按照方案,患者根据术前TNM分期进行分类:A组(TNM分期I - III)和B组(IVa - IVc)。A组患者在病例组中的患病率为59.6%,在对照组中为85.7%(P < 0.001),对照组随访时的生存率更高(80.5%对27.3%),因此,这两个历史组不具有可比性。鉴于病例数量有限,所有患者被纳入一个单独的组。OSCC的晚期阶段(对数秩检验,P < 0.001)和AN(P < 0.001)与较低的生存率独立相关。接受ON治疗的患者术后3 - 12个月MRI_C3体积增加,而接受AN治疗的患者则减少(P < 0.001)。

结论

在OSCC患者中,AN与比ON更低的生存概率相关。椎旁肌的MRI-C3测量是一种有前景的检测肌肉减少症的技术,需要通过包括更大患者群体的进一步研究来证实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/11948537/6296299c1369/fnut-12-1530460-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/11948537/ba4e477c60c3/fnut-12-1530460-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/11948537/adecc35824f4/fnut-12-1530460-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/11948537/2a092cb95f5d/fnut-12-1530460-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/11948537/f4046cd97c22/fnut-12-1530460-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/11948537/6296299c1369/fnut-12-1530460-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/11948537/ba4e477c60c3/fnut-12-1530460-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/11948537/adecc35824f4/fnut-12-1530460-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/11948537/2a092cb95f5d/fnut-12-1530460-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/11948537/f4046cd97c22/fnut-12-1530460-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6197/11948537/6296299c1369/fnut-12-1530460-g005.jpg

相似文献

1
Nutritional factors and survival in a cohort of patients with oral cancer.口腔癌患者队列中的营养因素与生存情况
Front Nutr. 2025 Mar 11;12:1530460. doi: 10.3389/fnut.2025.1530460. eCollection 2025.
2
CT-assessed sarcopenia and prognostic nutritional index are associated with poor prognosis in oral squamous cell carcinoma.CT 评估的肌肉减少症和预后营养指数与口腔鳞状细胞癌的不良预后相关。
Oral Maxillofac Surg. 2024 Jun;28(2):659-666. doi: 10.1007/s10006-023-01191-1. Epub 2023 Nov 8.
3
Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index.通过L3骨骼肌指数评估口腔鳞状细胞癌患者的预后。
Oral Dis. 2023 Apr;29(3):923-932. doi: 10.1111/odi.14074. Epub 2021 Nov 24.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Clinical correlation and survival analysis of hepatitis B virus infection in oral squamous cell carcinoma: a retrospective study of 1373 patients.口腔鳞状细胞癌中乙型肝炎病毒感染的临床相关性及生存分析:一项对1373例患者的回顾性研究
BMC Cancer. 2025 Apr 29;25(1):801. doi: 10.1186/s12885-025-14188-8.
6
Evaluation of sarcopenia and sarcopenic obesity in patients affected by oral squamous cell carcinoma: A retrospective single-center study.口腔鳞状细胞癌患者的肌肉减少症和肌肉减少性肥胖评估:一项回顾性单中心研究。
J Craniomaxillofac Surg. 2023 Jan;51(1):7-15. doi: 10.1016/j.jcms.2023.01.014. Epub 2023 Jan 30.
7
Impact of oral nutritional supplements in post-discharge patients at nutritional risk following colorectal cancer surgery: A randomised clinical trial.结直肠癌术后有营养风险出院患者口服营养补充的影响:一项随机临床试验。
Clin Nutr. 2021 Jan;40(1):47-53. doi: 10.1016/j.clnu.2020.05.038. Epub 2020 Jun 2.
8
Post-discharge oral nutritional supplements with dietary advice in patients at nutritional risk after surgery for gastric cancer: A randomized clinical trial.胃癌手术后营养风险患者出院后口服营养补充剂联合饮食建议的随机临床试验
Clin Nutr. 2021 Jan;40(1):40-46. doi: 10.1016/j.clnu.2020.04.043. Epub 2020 Jun 2.
9
Analysis of primary oral and oropharyngeal squamous cell carcinoma in inhabitants of Beijing, China-a 10-year continuous single-center study.中国北京居民原发性口腔及口咽鳞状细胞癌的分析——一项长达 10 年的连续单中心研究。
BMC Oral Health. 2020 Jul 17;20(1):208. doi: 10.1186/s12903-020-01192-6.
10
Customized nutrition intervention and personalized counseling helps achieve nutrition targets in perioperative liver transplant patients.定制化营养干预和个性化咨询有助于围手术期肝移植患者实现营养目标。
Clin Nutr ESPEN. 2018 Feb;23:200-204. doi: 10.1016/j.clnesp.2017.09.014. Epub 2017 Oct 26.

本文引用的文献

1
Evolution of the diagnosis of malnutrition in adults: a primer for clinicians.成人营养不良诊断的演变:临床医生入门指南
Front Nutr. 2024 Feb 6;11:1169538. doi: 10.3389/fnut.2024.1169538. eCollection 2024.
2
Ultrasound Muscle Evaluation for Predicting the Prognosis of Patients with Head and Neck Cancer: A Large-Scale and Multicenter Prospective Study.超声肌肉评估对头颈部癌症患者预后的预测价值:一项大规模多中心前瞻性研究。
Nutrients. 2024 Jan 29;16(3):387. doi: 10.3390/nu16030387.
3
Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma.
头颈部鳞状细胞癌的流行病学、危险因素和预防。
Med Sci (Basel). 2023 Jun 13;11(2):42. doi: 10.3390/medsci11020042.
4
Nutritional Management of Patients with Head and Neck Cancer-A Comprehensive Review.头颈部癌症患者的营养管理——全面综述。
Nutrients. 2023 Apr 13;15(8):1864. doi: 10.3390/nu15081864.
5
Impact of malnutrition as defined by the GLIM criteria on treatment outcomes in patients with cancer: A systematic review and meta-analysis.GLIM标准定义的营养不良对癌症患者治疗结局的影响:一项系统评价和荟萃分析。
Clin Nutr. 2023 May;42(5):615-624. doi: 10.1016/j.clnu.2023.02.019. Epub 2023 Feb 24.
6
Pretreatment Glasgow Prognostic Score Correlated with Serum Histidine Level and Three-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma and Optimal Performance Status.治疗前格拉斯哥预后评分与血清组氨酸水平及最佳体能状态局部晚期头颈部鳞状细胞癌患者 3 年死亡率的相关性。
Nutrients. 2022 Aug 24;14(17):3475. doi: 10.3390/nu14173475.
7
Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty.头颈部癌症患者肌肉减少症的测量及其与衰弱的关联。
Front Oncol. 2022 May 12;12:884988. doi: 10.3389/fonc.2022.884988. eCollection 2022.
8
The changing face of head and neck cancer: are patients with human papillomavirus-positive disease at greater nutritional risk? A systematic review.头颈部癌症的变化面貌:人乳头瘤病毒阳性疾病患者的营养风险更高吗?一项系统评价。
Support Care Cancer. 2022 Sep;30(9):7191-7204. doi: 10.1007/s00520-022-07056-9. Epub 2022 Apr 27.
9
Comparison of prophylactic percutaneous endoscopic gastrostomy with reactive enteral nutrition in patients with head and neck cancer undergoing radiotherapy or chemoradiotherapy: A systematic review.头颈部癌症患者放疗或放化疗中预防性经皮内镜胃造口术与反应性肠内营养的比较:系统评价。
Clin Nutr ESPEN. 2021 Dec;46:87-98. doi: 10.1016/j.clnesp.2021.09.724. Epub 2021 Oct 2.
10
Skeletal muscle mass at C3 is a strong predictor for skeletal muscle mass at L3 in sarcopenic and non-sarcopenic patients with head and neck cancer.在患有头颈癌的肌少症和非肌少症患者中,C3水平的骨骼肌质量是L3水平骨骼肌质量的有力预测指标。
Oral Oncol. 2021 Nov;122:105558. doi: 10.1016/j.oraloncology.2021.105558. Epub 2021 Oct 6.